Data-driven epidemiologic approach to conducting site feasibility for a global phase III tuberculosis vaccine clinical trial.
Saved in:
| Title: | Data-driven epidemiologic approach to conducting site feasibility for a global phase III tuberculosis vaccine clinical trial. |
|---|---|
| Authors: | Mui WL; EpiPointe, Cary, North Carolina, United States of America., Parekh FK; EpiPointe, Cary, North Carolina, United States of America., Tseng AS; EpiPointe, Cary, North Carolina, United States of America., Toro J; FHI Clinical, Durham, North Carolina, United States of America., Craig T; FHI Clinical, Durham, North Carolina, United States of America., Ndugga M; FHI Clinical, Durham, North Carolina, United States of America., Schmidt AC; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States of America., Dagnew AF; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States of America., Penz C; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States of America., Belai G; FHI Clinical, Durham, North Carolina, United States of America. |
| Source: | PLOS global public health [PLOS Glob Public Health] 2023 Nov 08; Vol. 3 (11), pp. e0002544. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 9918283779606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2767-3375 (Electronic) Linking ISSN: 27673375 NLM ISO Abbreviation: PLOS Glob Public Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37939024 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Data-driven epidemiologic approach to conducting site feasibility for a global phase III tuberculosis vaccine clinical trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mui+WL%22">Mui WL</searchLink>; EpiPointe, Cary, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Parekh+FK%22">Parekh FK</searchLink>; EpiPointe, Cary, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Tseng+AS%22">Tseng AS</searchLink>; EpiPointe, Cary, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Toro+J%22">Toro J</searchLink>; FHI Clinical, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Craig+T%22">Craig T</searchLink>; FHI Clinical, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Ndugga+M%22">Ndugga M</searchLink>; FHI Clinical, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Schmidt+AC%22">Schmidt AC</searchLink>; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Dagnew+AF%22">Dagnew AF</searchLink>; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Penz+C%22">Penz C</searchLink>; Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Belai+G%22">Belai G</searchLink>; FHI Clinical, Durham, North Carolina, United States of America. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918283779606676%22">PLOS global public health</searchLink> [PLOS Glob Public Health] 2023 Nov 08; Vol. 3 (11), pp. e0002544. <i>Date of Electronic Publication: </i>2023 Nov 08 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918283779606676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2767-3375 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227673375%22">27673375 </searchLink><i>NLM ISO Abbreviation: </i>PLOS Glob Public Health <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37939024 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1371/journal.pgph.0002544 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e0002544 Titles: – TitleFull: Data-driven epidemiologic approach to conducting site feasibility for a global phase III tuberculosis vaccine clinical trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mui WL – PersonEntity: Name: NameFull: Parekh FK – PersonEntity: Name: NameFull: Tseng AS – PersonEntity: Name: NameFull: Toro J – PersonEntity: Name: NameFull: Craig T – PersonEntity: Name: NameFull: Ndugga M – PersonEntity: Name: NameFull: Schmidt AC – PersonEntity: Name: NameFull: Dagnew AF – PersonEntity: Name: NameFull: Penz C – PersonEntity: Name: NameFull: Belai G IsPartOfRelationships: – BibEntity: Dates: – D: 08 M: 11 Text: 2023 Nov 08 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2767-3375 Numbering: – Type: volume Value: 3 – Type: issue Value: 11 Titles: – TitleFull: PLOS global public health Type: main |
| ResultId | 1 |